HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Oliver Sartor Selected Research

Castration

9/2014Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity.
9/2014Prostate cancer: the best fit for enzalutamide in metastatic prostate cancer.
6/2014Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
5/2014Radium-223 in metastatic castration resistant prostate cancer.
5/2014Treatment sequencing in metastatic castrate-resistant prostate cancer.
4/2014Castration-resistant prostate cancer: Adaptive responses in the androgen axis.
3/2014Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.
2/2014Castration-resistant prostate cancer: from new pathophysiology to new treatment.
12/2013Radium-223: the newest option in metastatic castration-resistant prostate cancer.
11/2013Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Oliver Sartor Research Topics

Disease

96Prostatic Neoplasms (Prostate Cancer)
09/2014 - 05/2002
29Neoplasms (Cancer)
04/2014 - 05/2002
10Neoplasm Metastasis (Metastasis)
06/2014 - 05/2004
8Disease Progression
03/2013 - 01/2004
5Pain (Aches)
11/2013 - 01/2004
4Adenocarcinoma
01/2013 - 03/2010
4Anemia
11/2012 - 05/2002
3Drug Toxicity (Drug Safety)
11/2012 - 05/2009
3Atrophy
12/2005 - 10/2004
2Lymphoma (Lymphomas)
08/2014 - 03/2010
2Progressive Multifocal Leukoencephalopathy
08/2014 - 05/2009
2Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 02/2006
2Kidney Diseases (Kidney Disease)
12/2012 - 11/2012
2Breast Neoplasms (Breast Cancer)
03/2012 - 01/2010
2Diarrhea
05/2010 - 01/2004
2Neutropenia
01/2010 - 05/2002
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2014
1Erectile Dysfunction
05/2014
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2014
1Chromosome Aberrations (Chromosome Abnormalities)
04/2014
1Renal Cell Carcinoma (Grawitz Tumor)
12/2012
1Multiple Myeloma
11/2012
1Myocardial Infarction
11/2012
1Venous Thromboembolism
11/2012
1Stroke (Strokes)
11/2012
1Prostatic Intraepithelial Neoplasia
05/2012
1Hypotension (Low Blood Pressure)
05/2010
1Fever (Fevers)
05/2010

Drug/Important Bio-Agent (IBA)

23Prostate-Specific Antigen (Semenogelase)IBA
05/2014 - 09/2002
22HormonesIBA
09/2014 - 05/2002
17docetaxel (Taxotere)FDA Link
06/2014 - 02/2008
9Androgen Receptors (Androgen Receptor)IBA
04/2014 - 09/2002
6Testosterone (Sustanon)FDA Link
10/2009 - 02/2003
5Prednisone (Sone)FDA LinkGeneric
01/2013 - 11/2009
54- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoateFDA Link
10/2011 - 01/2010
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2009 - 02/2003
4abirateroneIBA
10/2011 - 02/2011
4dutasteride (Avodart)FDA Link
11/2009 - 02/2009
3Dexamethasone (Maxidex)FDA LinkGeneric
09/2014 - 05/2010
3Hemoglobins (Hemoglobin)IBA
11/2013 - 05/2005
3HematinicsIBA
11/2012 - 03/2010
3Mitoxantrone (Novantrone)FDA LinkGeneric
01/2011 - 01/2008
3SaposinsIBA
12/2005 - 11/2004
2TaxoidsIBA
09/2014 - 06/2011
2Biological Markers (Surrogate Marker)IBA
05/2014 - 05/2009
2RadiopharmaceuticalsIBA
05/2014 - 05/2011
2Alkaline PhosphataseIBA
11/2013 - 05/2005
2Dihydrotestosterone (Androstanolone)IBA
03/2013 - 10/2009
2Thalidomide (Thalomid)FDA Link
11/2012 - 03/2009
2ErythropoietinFDA Link
11/2012 - 03/2012
2sipuleucel-T (APC8015)FDA Link
07/2012 - 10/2011
2taxaneIBA
06/2011 - 01/2010
2Ketoconazole (Nizoral)FDA LinkGeneric
11/2009 - 10/2009
2PlatinumIBA
11/2009 - 01/2008
2SamariumIBA
02/2007 - 01/2004
2Leuprolide (Lupron)FDA LinkGeneric
02/2006 - 08/2003
2Messenger RNA (mRNA)IBA
12/2005 - 05/2005
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2005 - 05/2005
2Phosphotransferases (Kinase)IBA
06/2005 - 11/2004
2prosaptideIBA
11/2004 - 10/2004
2Protein Kinases (Protein Kinase)IBA
11/2004 - 10/2004
2Radioisotopes (Radionuclides)IBA
01/2004 - 05/2003
2Estrogens (Estrogen)FDA Link
01/2004 - 02/2003
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2014
1GlucocorticoidsIBA
09/2014
1cAC10-vcMMAEIBA
08/2014
1Finasteride (Propecia)FDA LinkGeneric
05/2014
1Carbon MonoxideIBA
04/2014
1GTP Phosphohydrolases (GTPases)IBA
04/2014
1Conditioned Culture MediaIBA
04/2014
1sunitinib (Sutent)FDA Link
01/2014
1RadiumIBA
12/2013
1methaneselenolIBA
11/2013
1MDV 3100IBA
11/2013
1familial Prostate cancerIBA
05/2013
1Tuberculin (PPD)IBA
03/2013
1gadodiamide (Omniscan)FDA Link
12/2012
1Diethylstilbestrol (Stilbestrol)FDA Link
12/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2012
1Phenobarbital (Luminal)FDA Link
11/2012
1Glutamic Acid (Glutamate)FDA Link
11/2012
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2012
1Interleukin-17 (Interleukin 27)IBA
05/2012
1InterleukinsIBA
05/2012
1Counterfeit DrugsIBA
03/2012
1IsotopesIBA
09/2011
1BerberineIBA
08/2011
1denosumabFDA Link
07/2011
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
02/2011

Therapy/Procedure

36Castration
09/2014 - 02/2003
22Drug Therapy (Chemotherapy)
09/2014 - 10/2004
8Prostatectomy (Retropubic Prostatectomy)
07/2014 - 12/2007
6Heterologous Transplantation (Xenotransplantation)
09/2014 - 12/2005
3Aftercare (After-Treatment)
09/2011 - 03/2008
2Brachytherapy
01/2013 - 07/2012
1Radiotherapy
01/2013
1Nephrectomy
12/2012
1Therapeutics
05/2012
1Transplantation (Transplant Recipients)
03/2012